The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
Open accessAbstract
BACKGROUND: The level of the inactive N-terminal fragment of pro-brain (B-type) natriuretic peptide (BNP) is a strong predictor of mortality among patients with acute coronary syndromes and may be a strong prognostic marker in patients with chronic coronary heart disease as well. We assessed the relationship between N-terminal pro-BNP (NT-pro-BNP) levels and long-term mortality from all causes in a large cohort of patients with stable coronary heart disease. METHODS: NT-pro-BNP was measured in baseline serum samples from 1034 patients referred for angiography because of symptoms or signs of coronary heart disease. The rate of death from all causes was determined after a median follow-up of nine years. RESULTS: At follow-up, 288 patients had died. The median NT-pro-BNP level was significantly lower among patients who survived than among those who died (120 pg per milliliter [interquartile range, 50 to 318] vs. 386 pg per milliliter [interquartile range, 146 to 897], P<0.001). Patients with NT-pro-BNP levels in the highest quartile were older, had a lower left ventricular ejection fraction (LVEF) and a lower creatinine clearance rate, and were more likely to have a history of myocardial infarction, clinically significant coronary artery disease, and diabetes than patients with NT-pro-BNP levels in the lowest quartile. In a multivariable Cox regression model, the hazard ratio for death from any cause for the patients with NT-pro-BNP levels in the fourth quartile as compared with those in the first quartile was 2.4 (95 percent confidence interval, 1.5 to 4.0; P<0.001); the NT-pro-BNP level added prognostic information beyond that provided by conventional risk factors, including the patient's age; sex; family history with respect to ischemic heart disease; the presence or absence of a history of myocardial infarction, angina, hypertension, diabetes, or chronic heart failure; creatinine clearance rate; body-mass index; smoking status; plasma lipid levels; LVEF; and the presence or absence of clinically significant coronary artery disease on angiography. CONCLUSIONS: NT-pro-BNP is a marker of long-term mortality in patients with stable coronary disease and provides prognostic information above and beyond that provided by conventional cardiovascular risk factors and the degree of left ventricular systolic dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Epstein, F. H., Levin, E. R., Gardner, D. G., & Samson, W. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807303390507 · Cited by 1,927
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes
de Lemos, J. A., Morrow, D. A., Bentley, J. H., Omland, T., Sabatine, M. S., McCabe, C. H., Hall, C., Cannon, C. P., & Braunwald, E. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011053 · Cited by 1,284
Tsutamoto, T., Wada, A., Maeda, K., Hisanaga, T., Maeda, Y., Fukai, D., Ohnishi, M., Sugimoto, Y., & Kinoshita, M. (1997) · Circulation · doi:10.1161/01.cir.96.2.509 · Cited by 963
Sabatine, M. S., Morrow, D. A., de Lemos, J. A., Gibson, C. M., Murphy, S. A., Rifai, N., McCabe, C., Antman, E. M., Cannon, C. P., & Braunwald, E. (2002) · Circulation · doi:10.1161/01.cir.0000015464.18023.0a · Cited by 735
Omland, T., Aakvaag, A., Bonarjee, V. V. S., Caidahl, K., Lie, R. T., Nilsen, D. W. T., Sundsfjord, J. A., & Dickstein, K. (1996) · Circulation · doi:10.1161/01.cir.93.11.1963 · Cited by 700
Richards, A. M., Nicholls, M. G., Yandle, T. G., Frampton, C., Espiner, E. A., Turner, J. G., Buttimore, R. C., Lainchbury, J. G., Elliott, J. M., Ikram, H., et al. (1998) · Circulation · doi:10.1161/01.cir.97.19.1921 · Cited by 646
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction.
Morita, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M., & Nakao, K. (1993) · Circulation · doi:10.1161/01.cir.88.1.82 · Cited by 580
James, S. K., Lindahl, B., Siegbahn, A., Stridsberg, M., Venge, P., Armstrong, P., Barnathan, E. S., Califf, R., Topol, E. J., Simoons, M. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000079170.10579.dc · Cited by 579
N-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
Omland, T., Persson, A., Ng, L., O’Brien, R., Karlsson, T., Herlitz, J., Hartford, M., & Caidahl, K. (2002) · Circulation · doi:10.1161/01.cir.0000041661.63285.ae · Cited by 576
Essential Biochemistry and Physiology of (NT-pro)BNP
Hall, C. (2004) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2003.12.015 · Cited by 565
Gardner, R. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.07.005 · Cited by 448
Morrow, D. A., de Lemos, J. A., Sabatine, M. S., Murphy, S. A., Demopoulos, L. A., DiBattiste, P. M., McCabe, C. H., Gibson, C. M., Cannon, C. P., & Braunwald, E. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00168-2 · Cited by 419
Increased cardiac BNP expression associated with myocardial ischemia
Goetze, J. P., Christoffersen, C., Perko, M., Arendrup, H., Rehfeld, J. F., Rastrup, J., & Nielsen, L. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-0796fje · Cited by 353
Fox, K. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14974-4 · Cited by 300
McGowan, J. H., & Cleland, J. G. F. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00248-5 · Cited by 279
Long-term follow-up of coronary artery disease presenting in young adults
Cole, J. H., Miller, J. I., Sperling, L. S., & Weintraub, W. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02862-0 · Cited by 259
Bibbins-Domingo, K., Ansari, M., Schiller, N. B., Massie, B., & Whooley, M. A. (2003) · Circulation · doi:10.1161/01.cir.0000103681.04726.9c · Cited by 226
Autocrine and paracrine actions of natriuretic peptides in the heart
D'Souza, S. P., Davis, M., & Baxter, G. F. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.001 · Cited by 213
Wiviott, S. D., Cannon, C. P., Morrow, D. A., Murphy, S. A., Gibson, C. M., McCabe, C. H., Sabatine, M. S., Rifai, N., Giugliano, R. P., DiBattiste, P. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000109491.66226.26 · Cited by 190
Tateishi, J., Masutani, M., Ohyanagi, M., & Iwasaki, T. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231016 · Cited by 170
The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes
de Lemos, J. A., Morrow, D. A., & Bentley, J. H. (2002) · ACC Current Journal Review · doi:10.1016/s1062-1458(02)00522-6 · Cited by 147
Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina
Talwar, S., Squire, I. B., Downie, P. F., et al. (2000) · Heart · doi:10.1136/heart.84.4.421 · Cited by 139
Nilsson, J. C., Groenning, B. A., Nielsen, G., Fritz‐Hansen, T., Trawinski, J., Hildebrandt, P. R., Jensen, G. B., Larsson, H. B. W., & Søndergaard, L. (2002) · American Heart Journal · doi:10.1067/mhj.2002.120293 · Cited by 60
Self-citation
Cited by
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
Wang, T. J., Gona, P., Larson, M. G., Tofler, G. H., Levy, D., Newton-Cheh, C., Jacques, P. F., Rifai, N., Selhub, J., Robins, S. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055373 · Cited by 1,343
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,336
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Daniels, L. B., & Maisel, A. S. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.021 · Cited by 952
Santos-Gallego, C. G., Requena-Ibanez, J. A., San Antonio, R., Ishikawa, K., Watanabe, S., Picatoste, B., Flores, E., Garcia-Ropero, A., Sanz, J., Hajjar, R. J., et al. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.01.056 · Cited by 651
Metadata
- Authors
- Kragelund, C., Grønning, B., Køber, L., Hildebrandt, P., & Steffensen, R.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-02-17
- Volume
- 352
- Issue
- 7
- Pages
- 666-675
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1997808420
- Cited by
- 631
- References
- 25
- FWCI
- 46.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.